← Leaderboards
Robert S Warren
University Of California San Francisco
$3,470,409
Attributed
$3,470,409
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$3,470,409 · 1
By mechanism
R01$3,470,409 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California San Francisco
Same institution · by research overlap
- Gordon B. Mills$27,749,983
- Carolyn R Bertozzi$44,381,955
- William L Young$17,255,273
- Zena Werb$33,582,689
- John Kurhanewicz$27,913,734
Others in their field
Top investigators on “Cell Cycle”
- Bruce W Stillman · Cold Spring Harbor Laboratory$87,228,479
- Gregory D Peterson · University Of Tennessee Knoxville$84,527,696
- Nevan J Krogan · University Of California, San Francisco$83,822,021
- Mary M Horowitz · Medical College Of Wisconsin$76,714,344
- Frank Patrick McCormick · University Of California San Francisco$75,259,666
- David Heimbrook · Leidos Biomedical Research, Inc.$68,555,131
Research focus
Cell CycleClinical ResearchColon NeoplasmsDiagnosis Design /EvaluationDrug ResistanceGenetic MarkersGenomeHuman SubjectImmunomodulatorsMetastasisNeoplasm /Cancer Classification /StagingNeoplasm /Cancer DiagnosisNeoplasm /Cancer Relapse /RecurrencePrognosis
Grant awards (5)
MOLECULAR MARKERS OF PROGNOSIS IN COLON CANCER$654,271
R01 · FY2004 · CA
MOLECULAR MARKERS OF PROGNOSIS IN COLON CANCER$715,869
R01 · FY2003 · CA
MOLECULAR MARKERS OF PROGNOSIS IN COLON CANCER$681,710
R01 · FY2002 · CA
MOLECULAR MARKERS OF PROGNOSIS IN COLON CANCER$672,964
R01 · FY2001 · CA
MOLECULAR MARKERS OF PROGNOSIS IN COLON CANCER$745,595
R01 · FY2000 · CA